12 New Ways Companies Are Helping to Improve Adherence

PM360online.com

Specialty therapies face unique challenges surrounding patient safety, access to testing, mobility, and delays. Recent advancement of mobile ECGs help overcome these challenges, allowing patients to test within the privacy and convenience of their own home.

Leveraging AliveCor’s KardiaMobile 6L technology, IQVIA In Home Clinical Solutions pioneered a program among breast cancer patients that aimed to alleviate common pain points associated with ECG testing required for treatment.

The patients were provided a less invasive device which made it easier for them to take their own ECG readings. The program eliminated the need for the patients to travel to an office, significantly increasing the group’s adherence to treatment.

Key Takeaways

  • KardiaMobile 6L uniquely addresses challenges surrounding speciality therapies
  • The device offers a less invasive alternative to traditional 12L systems, mitigating additional and unnecessary pain points for cancer patients
  • Remote ECG monitoring can improve patient adherence to treatment

Read Full Article

The Broad Impact of QT Monitoring: Extending Beyond Cardiac Health into Diverse Conditions

Beyond its traditional focus on cardiac-specific therapies, every investigational drug can potentially impact cardiac function. What if we expanded QT monitoring across various therapeutic areas?

KardiaMobile® 6L Versus 12-lead ECG: Effects on Clinic Utilization Time

Wiley.com | Clinic utilization time is significantly reduced with the KardiaMobile® 6L compared to traditional 12L ECG systems. This study published in Wiley highlights how the 6L minimizes the need for frequent conventional 12L use.

Remote Monitoring and Data Collection for Decentralized Clinical Trials

JAMAnetwork.com | Patient-centric trials require accessible digital health technologies. A JAMA study explores the current state and aspired role of remote monitoring and data collection tools in oncology trials.